EMEA-001720-PIP01-14-M03 - paediatric investigation plan

Patiromer calcium

Key facts

• Invented name:
  Veltassa
• Active Substance:
  Patiromer calcium
• Therapeutic area:
  Other
• Decision number:
  P/0106/2023
• PIP number:
  EMEA-001720-PIP01-14-M03
• Pharmaceutical form(s):
  Powder for oral suspension
• Condition(s) / indication(s):
  Treatment of hyperkalaemia
• Route(s) of administration:
  Oral use
• Decision type:
  PM: decision on the application for modification of an agreed PIP
• Decision date:
  14/04/2023

Decision

P/0106/2023 : EMA decision of 14 April 2023 on the acceptance of a modification of an agreed paediatric investigation plan for patiromer calcium (Veltassa), (EMEA-001720-PIP01-14-M03)

Reference Number: EMA/143484/2023